WRCH1 Inhibitors
WRCH1 Inhibitors are a series of chemical compounds that target signaling pathways and cellular processes to decrease the functional activity of the Rho family GTPase WRCH1. For instance, ROCK inhibitor Y-27632 disrupts actin cytoskeleton organization through inhibition of the Rho-associated protein kinase, leading to diminished WRCH1 activity in cytoskeletal dynamics due to the close functional relationship between ROCK and Rho GTPases. Similarly, Rac1 inhibitors such as NSC 23766 and EHop-016 prevent Rac1 from interacting with its GEFs, indirectly reducing WRCH1 activity by disrupting shared regulatory mechanisms within the Rho GTPase family. Trio inhibitor ITX 3 and Cdc42 inhibitors like ML 141, CASIN, and ZCL278 further contribute to the indirect inhibition of WRCH1 by altering the signaling equilibrium among Rho GTPases, which is crucial for WRCH1's role in actin polymerization and cell morphology.
Additionally, compounds like Exoenzyme C3 Transferase specifically target other members of the Rho GTPase family, such as Cdc42 and RhoA, to indirectly suppress WRCH1 function. By inhibiting the activation of these GTPases without affecting their intrinsic GTPase activity, this inhibitor can cause a compensatory decrease in WRCH1-mediated processes. Moreover, Wiskostatin, by inhibiting the N-WASP–Arp2/3 complex interaction essential for actin polymerization, indirectly lessens WRCH1's contribution to the formation of cytoskeletal structures. The collective action of these inhibitors results in a comprehensive dampening of WRCH1's activity across various cellular pathways, emphasizing the interconnected nature of Rho GTPase signaling and the intricate balance required for maintaining cellular functions such as stress fiber formation, cell shape maintenance, and migration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor Y-27632 selectively inhibits the Rho-associated protein kinase (ROCK), which is a downstream effector of the Rho family of GTPases, including WRCH1. Inhibition of ROCK leads to the disruption of actin cytoskeleton organization and cellular contraction, processes in which WRCH1 is implicated, thereby indirectly diminishing WRCH1's functional role in cytoskeletal dynamics. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
CDC42 inhibitor ML 141 selectively inhibits the GTPase CDC42, which closely interacts with the Rho family of GTPases. By inhibiting CDC42, the cellular balance of Rho GTPase signaling is altered, indirectly diminishing WRCH1's involvement in actin polymerization and cell shape maintenance. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $80.00 | ||
Rac1 inhibitor EHop-016 blocks Rac1 interaction with Vav2, a GEF, thereby inhibiting Rac1-mediated signal transduction. As Rac1 and WRCH1 are part of the Rho GTPase family and functionally interconnected, EHop-016's action can indirectly diminish WRCH1's role in modulating the actin cytoskeleton and cell migration. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
Trio inhibitor ITX 3 specifically inhibits the GEF activity of Trio towards Rac1 and RhoG, which are related to WRCH1 in the Rho GTPase family. By inhibiting Trio, the downstream Rho GTPase signaling is affected, indirectly reducing WRCH1 activity in processes such as cell morphology regulation. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
Cdc42 activity-specific inhibitor (CASIN) selectively targets CDC42, affecting the balance of Rho GTPase activities including that of WRCH1. CASIN's inhibition of CDC42 can indirectly lead to the diminished function of WRCH1 in actin organization and cellular signaling pathways. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Rhosin specifically binds to RhoA and inhibits its interaction with GEFs, thereby disrupting RhoA signaling. Inhibition of RhoA can lead to an imbalance in the Rho GTPase family activities, including that of WRCH1, and indirectly decrease WRCH1's role in cellular processes like stress fiber formation. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
Cdc42 inhibitor ZCL278 disrupts the interaction between Cdc42 and its GEF intersectin, leading to inhibited Cdc42 signaling. This inhibition can indirectly diminish WRCH1 activity due to the interplay between Cdc42 and other Rho GTPases in regulating the actin cytoskeleton and related cellular functions. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is a selective inhibitor of the N-WASP–Arp2/3 complex interaction, which is crucial for actin polymerization and network formation. Although Wiskostatin does not directly inhibit WRCH1, it disrupts actin dynamics, a process in which WRCH1 is involved, leading to an indirect reduction of WRCH1's functional contribution to cytoskeletal rearrangements. | ||||||